Evidence map›Paper›PMID 25926446›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidus.

Azzedine Abdi, Nicolas Mallet, Foad Y Mohamed, Andrew Sharott, Paul D Dodson, Kouichi C Nakamura, Sana Suri, Sophie V Avery, Joseph T Larvin, Farid N Garas and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Temporal Variability in the Spiking Activity of Neurons in the External Globus Pallidus in Healthy and Parkinsonian Monkeys.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Synaptic integration and competition in the substantia nigra pars reticulata-An experimental and in silico analysis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Azzedine AbdiUniversité de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France.
Nicolas MalletUniversité de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.ORCID http://orcid.org/0000-0003-2904-4384
Foad Y MohamedMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Andrew SharottMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Paul D DodsonMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and Oxford Parkinson's Disease Centre, University of Oxford, Oxford OX1 3QX, United Kingdom.ORCID http://orcid.org/0000-0003-0858-6088
Kouichi C NakamuraMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.ORCID http://orcid.org/0000-0001-7053-0507
Sana SuriMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Sophie V AveryMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Joseph T LarvinMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.ORCID http://orcid.org/0000-0002-5828-1138
Farid N GarasMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Shady N GarasMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Federica VinciatiMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and.
Stéphanie MorinUniversité de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France.
Erwan BezardUniversité de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France.ORCID http://orcid.org/0000-0002-0410-4638
Jérôme BaufretonUniversité de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, peter.magill@pharm.ox.ac.uk jerome.baufreton@u-bordeaux2.fr.ORCID http://orcid.org/0000-0002-2623-6375
Peter J MagillMedical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and Oxford Parkinson's Disease Centre, University of Oxford, Oxford OX1 3QX, United Kingdom peter.magill@pharm.ox.ac.uk jerome.baufreton@u-bordeaux2.fr.
University of Oxford · GBUniversité de Bordeaux · FR

Funding

Medical Research Council MC_U138197109Medical Research Council MC_UU_12020/5Medical Research Council MC_UU_12024/1Medical Research Council MC_UU_12024/2Medical Research Council UU138197109Parkinson's UK G-0806Parkinson's UK J-0901Wellcome TrustWellcome Trust 099711Wellcome Trust 101821
6 · The paper itself

Abstract

Studies in dopamine-depleted rats indicate that the external globus pallidus (GPe) contains two main types of GABAergic projection cell; so-called "prototypic" and "arkypallidal" neurons. Here, we used correlative anatomical and electrophysiological approaches in rats to determine whether and how this dichotomous organization applies to the dopamine-intact GPe. Prototypic neurons coexpressed the transcription factors Nkx2-1 and Lhx6, comprised approximately two-thirds of all GPe neurons, and were the major GPe cell type innervating the subthalamic nucleus (STN). In contrast, arkypallidal neurons expressed the transcription factor FoxP2, constituted just over one-fourth of GPe neurons, and innervated the striatum but not STN. In anesthetized dopamine-intact rats, molecularly identified prototypic neurons fired at relatively high rates and with high regularity, regardless of brain state (slow-wave activity or spontaneous activation). On average, arkypallidal neurons fired at lower rates and regularities than prototypic neurons, and the two cell types could be further distinguished by the temporal coupling of their firing to ongoing cortical oscillations. Complementing the activity differences observed in vivo, the autonomous firing of identified arkypallidal neurons in vitro was slower and more variable than that of prototypic neurons, which tallied with arkypallidal neurons displaying lower amplitudes of a "persistent" sodium current important for such pacemaking. Arkypallidal neurons also exhibited weaker driven and rebound firing compared with prototypic neurons. In conclusion, our data support the concept that a dichotomous functional organization, as actioned by arkypallidal and prototypic neurons with specialized molecular, structural, and physiological properties, is fundamental to the operations of the dopamine-intact GPe.

Indexed as

Action PotentialsAdrenergic AgentsAnimalsAnimals, NewbornDopamineELAV-Like Protein 3ELAV ProteinsFemaleForkhead Transcription FactorsGlobus PallidusGreen Fluorescent ProteinsIn Vitro TechniquesNeural PathwaysNeuronsNuclear ProteinsOxidopamineAdrenergic AgentsDopamineElavl3 protein, ratELAV-Like Protein 3ELAV Proteinsenhanced green fluorescent proteinForkhead Transcription FactorsFoxp2 protein, ratGreen Fluorescent ProteinsNkx2-1 protein, ratNuclear ProteinsOxidopamineParvalbuminsThyroid Nuclear Factor 1Transcription Factorsanatomyarkypallidalbasal gangliaelectrophysiologyglobus pallidustranscription factor

Identifiers

PMID25926446
PMCPMC4412890
OpenAlexW2119156931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.